Natalizumab-associated progressive multifocal leucoencephalopathy: a report of 3 cases, and implications for successful treatment

被引：0
|
作者：
Kalamatas, T. [1 ]
Travasarou, M. [1 ]
Giannouli, E. [1 ]
Marousi, S. [1 ]
Samara, C. [1 ]
Karageorgiou, K. [1 ]
机构：
[1] G Gennimatas Athens Gen Hosp, Athens, Greece
来源：
MULTIPLE SCLEROSIS JOURNAL | 2011年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P999
引用
收藏
页码：S454 / S454
页数：1
相关论文
共 50 条
  • [21] Unusual natalizumab-associated progressive multifocal leukoencephalopathy starting in the brainstem
    Joachim Havla
    Reinhard Hohlfeld
    Tania Kümpfel
    Journal of Neurology, 2014, 261 : 232 - 234
  • [22] Commentary on "Successful pregnancy after natalizumab-associated progressive multifocal leukoencephalopathy in a patient with multiple sclerosis"
    Arrambide, Georgina
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (03) : 486 - 487
  • [23] Diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy using MRI
    Wattjes, Mike P.
    Barkhof, Frederik
    CURRENT OPINION IN NEUROLOGY, 2014, 27 (03) : 260 - 270
  • [24] TSPO PET imaging of natalizumab-associated progressive multifocal leukoencephalopathy
    Mahler, Christoph
    Schumacher, Adrian-Minh
    Unterrainer, Marcus
    Kaiser, Lena
    Hollbacher, Thomas
    Lindner, Simon
    Havla, Joachim
    Ertl-Wagner, Birgit
    Patzig, Maximilian
    Seelos, Klaus
    Neitzel, Julia
    Maurer, Matthias
    Krumbholz, Markus
    Metz, Imke
    Bruck, Wolfgang
    Stadelmann, Christine
    Merkler, Doron
    Gass, Achim
    Milenkovic, Vladimir
    Bartenstein, Peter
    Albert, Nathalie L.
    Kuempfel, Tania
    Kerschensteiner, Martin
    BRAIN, 2021, 144 : 2683 - 2695
  • [25] Prophylactic antiepileptic treatment reduces seizure frequency in natalizumab-associated progressive multifocal leukoencephalopathy
    Hoepner, Robert
    Dahlhaus, Stefanie
    Kollar, Susanne
    Zurawski, Barbara
    Chan, Andrew
    Kleiter, Ingo
    Gold, Ralf
    Hellwig, Kerstin
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2014, 7 (01) : 3 - 6
  • [26] Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases
    Clifford, David B.
    DeLuca, Andrea
    Simpson, David M.
    Arendt, Gabriele
    Giovannoni, Gavin
    Nath, Avindra
    LANCET NEUROLOGY, 2010, 9 (04): : 438 - 446
  • [27] Overview of survival outcome and functional status in postmarketing cases of natalizumab-associated progressive multifocal leukoencephalopathy
    Kappos, L.
    Foley, J.
    Gold, R.
    Olsson, T.
    Vermersch, P.
    Bozic, C.
    Cadavid, D.
    Richert, N.
    Richman, S.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S131 - S131
  • [28] Progressive Multifocal Leucoencephalopathy: Report of Two Diverse Cases
    Masoodi, I
    Farooq, Omar
    Ahmad, Iqbal
    Yassin, Mohamad
    INTERNATIONAL JOURNAL OF HEALTH SCIENCES-IJHS, 2009, 3 (02): : 227 - 231
  • [29] Successful Management of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy and Immune Reconstitution Syndrome in a Patient With Multiple Sclerosis
    Schroeder, Alexandra
    Lee, De-Hyung
    Hellwig, Kerstin
    Lukas, Carsten
    Linker, Ralf A.
    Gold, Ralf
    ARCHIVES OF NEUROLOGY, 2010, 67 (11) : 1391 - 1394
  • [30] Course of neuropsychological impairment during natalizumab-associated progressive multifocal leukoencephalopathy
    Kinner, Markus
    Prehn, Christian
    Schneider, Ruth
    Schroeder, Christoph
    Kolb, Eva
    Gold, Ralf
    Hoepner, Robert
    Chan, Andew
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 (03) : 921 - 927
12345